PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsTramadol
Tramadol
Conzip, Qdolo, Seglentis, Tramadol (tramadol) is a small molecule pharmaceutical. Tramadol was first approved as Ultram on 1995-03-03. It is used to treat pain in the USA.
Download report
Favorite
Searched
Top Prescription Drugs
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
psychological phenomenaD011579
musculoskeletal and neural physiological phenomenaD055687
Trade Name
FDA
EMA
Conzip, Qdolo (generic drugs available since 2002-06-19, discontinued: Rybix, Ryzolt, Ultram)
Combinations
Seglentis (generic drugs available since 2002-06-19, discontinued: Ultracet)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Acetaminophen
+
Tramadol hydrochloride
Tradename
Company
Number
Date
Products
ULTRACETJohnson & JohnsonN-021123 DISCN2001-08-15
1 products, RLD
Hide discontinued
Celecoxib
+
Tramadol hydrochloride
Tradename
Company
Number
Date
Products
SEGLENTISKowaN-213426 RX2021-10-15
1 products, RLD, RS
Tramadol hydrochloride
Tradename
Company
Number
Date
Products
QDOLOAthena NeurosciencesN-214044 RX2020-09-01
1 products, RLD, RS
CONZIPCipher PharmaceuticalsN-022370 RX2010-05-07
3 products, RLD
Show 5 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
banana boat kids ultramist tear free spf 30OTC monograph final2010-03-25
banana boat ultramist baby tear free continuous spf 50OTC monograph final2010-03-18
banana boat ultramist kids spf 50 factor de proteccion solar 50OTC monograph final2010-03-21
banana boat ultramist kids tear free lotion spf 50OTC monograph final2010-03-21
banana boat ultramist sport performance spf 50OTC monograph final2010-03-20
direct rxANDA2015-09-09
griseofulvinANDA2021-07-21
seglentisNew Drug Application2023-12-27
tramadol acetaminophenANDA2016-06-22
tramadol hcl and acetaminophenANDA2020-07-15
Show 4 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
painEFO_0003843D010146R52
Agency Specific
FDA
EMA
Expiration
Code
CELECOXIB / TRAMADOL HYDROCHLORIDE, SEGLENTIS, KOWA PHARMS
2024-10-15NP
Patent Expiration
Patent
Expires
Flag
FDA Information
Tramadol Hydrochloride, Qdolo, Athena
111034522040-09-01DPU-3197
117521032040-09-01DPU-3197
Celecoxib / Tramadol Hydrochloride, Seglentis, Kowa Pharms
88467442031-06-03DP
85981522030-04-19DS, DP
90124402030-04-19DS, DP
102386682030-04-19DS, DPU-3244
102452762030-04-19DS, DP
105489092030-04-19U-3244
114784882030-04-19U-3244
ATC Codes
N: Nervous system drugs
N02: Analgesics
N02A: Opioid analgesics
N02AJ: Opioids in combination with non-opioid analgesics
N02AJ13: Tramadol and paracetamol
N02AJ14: Tramadol and dexketoprofen
N02AJ15: Tramadol and other non-opioid analgesics
N02AJ16: Tramadol and celecoxib
N02AX: Other opioids in atc
N02AX02: Tramadol
HCPCS
No data
Clinical
Clinical Trials
537 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Postoperative painD010149G89.18233315190
PainD010146EFO_0003843R5210716191870
Acute painD059787R52575724
Chronic painD059350HP_00125324102823
Healthy volunteers/patients164121
Low back painD017116HP_0003419M54.51353820
AnalgesiaD000698126715
AnesthesiaD00075815713
OsteoarthritisD010003EFO_0002506M15-M192217113
Laparoscopic cholecystectomyD017081167
Show 86 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Wounds and injuriesD014947T14.8123
Squamous cell carcinoma of head and neckD00007719511
PruritusD011537HP_0000989L2911
NauseaD009325HP_0002018R11.011
VertigoD014717H81.3911
Laron syndromeD046150Orphanet_633E34.32111
Major depressive disorderD003865EFO_0003761F2211
MelanomaD008545111
Eye neoplasmsD005134EFO_0003824C69.9111
Shoulder fracturesD012784S42.911
Show 6 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Therapeutic equivalencyD01381022
Brain injuriesD001930S06.911
Consciousness disordersD00324411
Persistent vegetative stateD018458R40.311
AgingD000375GO_0007568R41.8111
Biological availabilityD00168211
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Nerve blockD00940744
ObesityD009765EFO_0001073E66.933
AnxietyD001007EFO_0005230F41.133
Morbid obesityD009767EFO_000107433
NephrolithiasisD053040N20.022
Lung neoplasmsD008175HP_0100526C34.9022
CholecystectomyD00276322
Tuberous sclerosisD014402HP_0009720Q85.122
Cancer painD000072716G89.322
Coronary artery diseaseD003324I25.111
Show 53 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTramadol
INNtramadol
Description
(R,R)-tramadol is a 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol in which both stereocentres have R-configuration; the (R,R)-enantiomer of the racemic opioid analgesic tramadol, it exhibits ten-fold higher analgesic potency than the (S,S)-enantiomer. It has a role as a delta-opioid receptor agonist, a kappa-opioid receptor agonist, a mu-opioid receptor agonist, an adrenergic uptake inhibitor, an antitussive, a capsaicin receptor antagonist, a muscarinic antagonist, a nicotinic antagonist, a NMDA receptor antagonist, an opioid analgesic, a serotonergic antagonist, a serotonin uptake inhibitor and a metabolite. It is a conjugate base of a (R,R)-tramadol(1+). It is an enantiomer of a (S,S)-tramadol.
Classification
Small molecule
Drug classanalgesics (mixed opiate receptor agonists/antagonists)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
COc1cccc(C2(O)CCCCC2CN(C)C)c1
Identifiers
PDB
CAS-ID2914-77-4
RxCUI
ChEMBL IDCHEMBL1237044
ChEBI ID75722
PubChem CID33741
DrugBankDB00193
UNII ID39J1LGJ30J (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Tramadol
+
Acetaminophen
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tramadol
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 87,655 documents
View more details
Safety
Black-box Warning
Black-box warning for: Direct rx, Seglentis, Tramadol acetaminophen, Tramadol hcl and acetaminophen, Tramadol hydrochloride and acetaminophen, Ultracet
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
65,910 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use